Therefore, Pde5a low expression in lung TCs may have therapeutic effect on pulmonary fibrosis and other acute and chronic interstitial lung disease, probably by modulation of oxidative stress levels, as previously shown 41. The gene discussed is PDE5A; the disease is pulmonary fibrosis.